Indications

• Non-Insulin Dependent Diabetes Mellitus (NIDDM) (see Diabetes Mellitus, [[Diabetes Mellitus]])

---

Pharmacology

• Second-Generation Sulfonylurea (see Sulfonylureas, [[Sulfonylureas]])

---

Administration

• PO

---

Adverse Effects

Gastrointestinal Adverse Effects

• Asymptomatic Elevation of Hepatic Transaminases (Isolated Transaminitis) (see Drug-Induced Hepatotoxicity, [[Drug-Induced Hepatotoxicity]])

Other Adverse Effects

• xxx

---

References

• xxxx